CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$5.06
-0.08 (-1.56%)
▼
5d:
+5.2%
30d:
+40.56%
90d:
+173.51%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLOV trades at premium valuation expecting 13.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CLOV trades at premium valuation expecting 13.9% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $5.06, which is considered extended relative to its 30-day fair value range of $3.56 to $4.75. From a valuation perspective, the stock is trading at a premium (Forward PE: 50.6) compared to its historical average (34.3). At these levels, the market is pricing in 13.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLOV is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $5.35.
Market Sentiment: CLOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.15. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLOV is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $5.35.
Market Sentiment: CLOV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.15. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.56 -
$4.75
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
Protect Your Profits
CLOV is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 18.0% above Wall St target ($4.15)
- NEUTRAL: Trading at premium valuation - market expects 13.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$3.56 -
$4.75
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.92
Resistance Level
$5.35
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.60
Wall Street Target
$4.15
(-18.0%)
Revenue Growth (YoY)
62.0%
Profit Margin
-2.6%
Valuation Premium vs History
+13.9% premium
PE vs Historical
50.6 vs 34.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+13.9%
(market-implied from PE analysis)
1-Year Target
$5.76
(+14%)
2-Year Target
$6.56
(+30%)
3-Year Target
$7.48
(+48%)
3-Yr Target (if PE normalizes)
(PE: 51→34)
PE COMPRESSION
$5.07
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 50.6, Growth: 11.1%)
$6.94
(+37%)
Base:
(SPY PE: 21.8, Growth: 11.1%)
$2.99
(-41%)
Bear:
(PE: 18.5, Growth: 11.1%)
$2.54
(-50%)
Share & Embed Analysis
Last updated: June 24, 2026 12:12 AM ET
Data refreshes hourly during market hours. Next update: 1:12 AM
Data refreshes hourly during market hours. Next update: 1:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 64 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 55 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 55 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$416 | 58 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$302 | 59 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
